banda transcan 2 2016ul


ERA-NET TRANSCAN-3

The consortium of the new project: TRANSCAN-3 Sustained collaboration of national and regional programmes in cancer research, funded by the European Commission under Horizon 2020 from 2021 to 2026 (Grant Agreement no. 964264),

has launched its first Joint Transnational Call co-funded by the European Commission (JTC 2021)

on the topic:

"Next generation cancer immunotherapy: targeting the tumour microenvironment"

28 funding organizations from 19 countries are participating.

The submission deadline for pre-proposals is on 29thof June 2021.
It is expected that consortia invited for the full-proposal stage will be asked to submit their proposal on November 2021.

go to the call web page


ERA-NET TRANSCAN-2

The ERA-NET: Aligning national/regional translational cancer research programmes and activities - TRANSCAN-2 is a project funded by the European Commission under the EU framework programme Horizon2020 (Grant Agreement no. 643638) from 2015 to 2021.

It is the continuation of the previous ERA-NET on translational cancer research TRANSCAN, funded under the FP7 from 2011 to 2014.

TRANSCAN-2 is a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research. The network is composed of 31 partners from 19 Countries.

 Coordination:
The project is coordinated by the Ministry of Health, Italy
Coordinator: Dr. Giovanni Leonardi. Deputy coordinator: Dr. Gaetano Guglielmi


Contact:
Dr. Silvia Paradisi
Project Manager
Italian National Institute of Health
Viale Regina Elena, 299
00161 Rome, Italy
 
mail to: This email address is being protected from spambots. You need JavaScript enabled to view it.


TRANSCAN News

Launch of the call: JTC 2021
The new TRANSCAN-3 project consortium is launching the first Joint Transnational Call for proposals, co-funded by the European Commission, on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment"

International Networking Event (virtual)
on 22 April 2021 hrs 9:00 CET
will focus on the forthcoming co-funded JTC 2021 on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment" 
the event is organized by TUBITAK under the “Turkey in Horizon 2020 Phase II” Technical Assistance Project
in cooperation with TRANSCAN-3

ERA-NET Cofund TRANSCAN-3:
 Sustained collaboration of national and regional programmes in cancer research
is the new project funded by the European Commission under H2020  which started on 1st March 2021 and will last five years (G. A. no. 964264)

A TRANSCAN-2 brochure, highlighting key achievements, is available for download

 

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.

Who's Online

We have 12 guests and no members online